Cardiology

Study compares bivalirudin and heparin in patients undergoing percutaneous coronary intervention

Bivalirudin offers a slightly better coagulation function and safety profile compared to heparin in patients undergoing percutaneous coronary intervention (PCI), while both drugs are equally effective in preventing postoperative cardiovascular events, according to a study. The research included 42 patients with coronary heart disease treated with bivalirudin or heparin during...